This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pantel, J. Articles by Amselem, S. Search for Related Content PubMed PubMed Citation Articles by Pantel, J. Articles by Amselem, S.

Heterozygous Nonsense Mutation in Exon 3 of the Growth Hormone Receptor (GHR) in Severe GH Insensitivity (Laron Syndrome) and the Issue of the Origin and Function of the GHRd3 Isoform

Institut National de la Santé et de la Recherche Médicale, Unité-468 (J.P., S.A.), Hôpital Henri Mondor, 94010 Créteil, France; Division of Pediatric Endocrinology (J.G.-H., M.B., U.H.), University Children’s Hospital, D-69120 Heidelberg, Germany; and Division of Endocrinology, Department of Internal Medicine (C.J.S.), 10117 Berlin, Germany

Address all correspondence and requests for reprints to: Pr. Serge Amselem, INSERM-U468, Hôpital Henri Mondor, 51 avenue Maréchal de Lattre de Tassigny, 94010 Créteil, France. E-mail: serge.amselem{at}im3.inserm.fr.

Mutations in the GH receptor gene (GHR) cause congenital GH insensitivity, a genetic disorder characterized by severe growth retardation associated with high serum concentration of GH and low serum levels of IGF-I. Molecular defects have been identified in all GHR-coding exons, except exon 3, a sequence that encodes part of the extracellular domain of the receptor. In humans, GHR transcripts exist in two isoforms differing by the retention (GHRfl) or exclusion (GHRd3) of this particular exon. As shown recently, such a dimorphic expression pattern, of unknown significance, could result from a retrovirus-mediated deletion event involving exon 3. This model for the generation of those two isoforms, however, leaves open the possibility that GHRd3 transcripts also arise from GHRfl alleles through alternative splicing. Here we report the identification of the first mutation in exon 3 of the GHR (W16X) in a patient with GH insensitivity and who also carries another nonsense mutation in exon 4. Intrafamilial correlation analyses of genotypes (presence of normal or mutant GHRfl and/or GHRd3 alleles), GHR expression patterns, and phenotypes provided direct evidence against an alternative splicing of exon 3. In particular, this exon was retained into transcripts originating from the GHRfl-W16X allele in both the patient and his mother. These observations, given the normal phenotype of the heterozygous parents, revealed also that a single copy of either GHRfl or GHRd3 is sufficient for normal growth.

This work was supported by the Institut National de la Santé et de la Recherche Médicale.

J.P. and J.G.-H. contributed equally to this work.

Abbreviations: EBV, Epstein-Barr virus; GHBP, binding protein for GH; GHI, GH insensitivity; GHR, GH receptor gene; GHRd3, GHR transcript isoform with the exclusion of exon 3; GHRfl, GHR transcript isoform with the retention of exon 3; hGH, human GH; IGFBP, IGF-binding protein; PTC, premature stop codon.

This article has been cited by other articles:

				O R Adetunji, I A MacFarlane, M Javadpour, A Alfirevic, M Pirmohamed, and J C Blair The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy Eur. J. Endocrinol., October 1, 2009; 161(4): 541 - 546. [Abstract] [Full Text] [PDF]

				M. J. E. Wassenaar, O. M. Dekkers, A. M. Pereira, J. M. Wit, J. W. Smit, N. R. Biermasz, and J. A. Romijn Impact of the Exon 3-Deleted Growth Hormone (GH) Receptor Polymorphism on Baseline Height and the Growth Response to Recombinant Human GH Therapy in GH-Deficient (GHD) and Non-GHD Children with Short Stature: A Systematic Review and Meta-Analysis J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3721 - 3730. [Abstract] [Full Text] [PDF]

				B. Raz, M. Janner, V. Petkovic, D. Lochmatter, A. Eble, M. T. Dattani, P. C. Hindmarsh, C. E. Fluck, and P. E. Mullis Influence of Growth Hormone (GH) Receptor Deletion of Exon 3 and Full-Length Isoforms on GH Response and Final Height in Patients with Severe GH Deficiency J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 974 - 980. [Abstract] [Full Text] [PDF]

				P. Fang, S. Riedl, S. Amselem, K. L. Pratt, B. M. Little, G. Haeusler, V. Hwa, H. Frisch, and R. G. Rosenfeld Primary Growth Hormone (GH) Insensitivity and Insulin-Like Growth Factor Deficiency Caused by Novel Compound Heterozygous Mutations of the GH Receptor Gene: Genetic and Functional Studies of Simple and Compound Heterozygous States J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2223 - 2231. [Abstract] [Full Text] [PDF]

				R. G. Rosenfeld The Pharmacogenomics of Human Growth. J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 795 - 796. [Full Text] [PDF]

				G. Binder, F. Baur, R. Schweizer, and M. B. Ranke The d3-Growth Hormone (GH) Receptor Polymorphism Is Associated with Increased Responsiveness to GH in Turner Syndrome and Short Small-for-Gestational-Age Children J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 659 - 664. [Abstract] [Full Text] [PDF]